Sökning: id:"swepub:oai:DiVA.org:umu-41026" >
Hyperferritinemia i...
Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts.
-
- Wahlin, Anders (författare)
- Umeå universitet,Onkologi,Department of Hematology, Cancer Centre, University Hospital, 90185 Umea, Sweden
-
- Lorenz, Fryderyk (författare)
- Umeå universitet,Onkologi,Hematology, Department of Radiation Sciences
-
- Fredriksson, Maritha (författare)
- Department of Hematology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
-
visa fler...
-
- Remberger, Mats (författare)
- Karolinska Institutet
-
- Wahlin, Björn E (författare)
- Karolinska Institutet
-
- Hägglund, Hans (författare)
- Department of Hematology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2010-04-15
- 2011
- Engelska.
-
Ingår i: Medical Oncology. - : Springer Science and Business Media LLC. - 1357-0560 .- 1559-131X. ; 28:2, s. 552-558
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- High pre-transplantation serum ferritin levels have been reported to be associated with impaired survival post-transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome. We performed a retrospective study of 309 patients who underwent allogeneic hematopoietic stem cell transplantation at two transplantation centers. The aim was to determine the effect of pre-transplantation hyperferritinemia on survival, graft versus host disease, and relapse. In both univariate and multivariate analysis, elevated ferritin levels were significantly associated with shorter overall and relapse-free survival times and increased relapse rate, but lower risk of chronic graft versus host disease. Elevated ferritin levels were not associated with non-relapse mortality. We hypothesize that ferritin may exert an immunosuppressive effect, reducing graft versus host disease and graft versus leukemia effects, resulting in increased risk of relapse and impaired survival.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- Ferritin
- Graft versus host disease
- Relapse
- Survival
- Immunosuppressive
- Oncology
- onkologi
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas